Esper Bionics

Esper Bionics

Private
New York City, New YorkHealthcare & Life Scienceshttps://esperbionics.com

Last Round

Series A

Jun 28, 2024

Total Funding Raised

$5.32M

Momentum Score

25 /100

Company Overview

Esper Bionics is a healthtech company developing an AI-powered bionic ecosystem that includes robotic limbs and controllers for people with limb differences.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Industrial Robotics, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

bionic handAI-powered prosthesishuman augmentationEMG sensorsprostheticsmyoelectric controlrobotic armself-learning prosthesisbrain-computer interfaceBCIAI medical deviceprosthetic clinicscloud AI platformFDA-registeredcyborg technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Esper Bionics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Esper Bionics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 28, 2024
GrantMay 18, 2024
GrantAug 26, 2022
AcceleratorOct 5, 2021
SeedSep 3, 2020
Grant
Apr 17, 2019

Key People

Founding team and executive leadership

Dima Gazda

Founder, CEO

Founding Team

Halyna Tahiyeva

Chief Financial Officer

Executive Team

Vitalii Sahan

CPO (Sensors)

Executive Team

Esper Bionics Investors

Notable investors and investment history

Esper Bionics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Esper Bionics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Esper Bionics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range55
Year Founded2019
Last FundingJun 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.